MICHELLE KING: Open Payments
NPI 1659951911 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$152 in 9 payments from 5 companies in 2025. Trend: 2023 $14 · 2024 $224 · 2025 $152
Food & beverage: $152
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $62 |
| Novo Nordisk Inc | 2 | $31 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $14 |
Products named: Ozempic, FARXIGA, TRELEGY ELLIPTA, FANAPT, BREZTRI, JARDIANCE, AIRSUPRA.
Industry payments across KY — which companies pay providers there.
